miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 1, 2026

Trump made $1B on crypto, his buyers got crushed

View original at finance.yahoo.com
Trump made $1B on crypto, his buyers got crushed Scott Melker discusses President Trump's latest financial disclosures, which show he earned nearly $1 billion from crypto-related ventures, while many investors in Trump-branded crypto tokens have suffered huge losses…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Citigroup cut its year-end Bitcoin target from $112k to $82k and its Ether target from $3,175 to $2,240

    60% confidence
  • Coinbase makes more money on USDC than Circle does

    60% confidence
  • Trump made almost a billion and a half dollars on crypto in 2025 according to his own 900-plus page disclosure

    60% confidence
  • Trump's net effect on the crypto industry is roughly zero, with negatives and positives balancing out

    60% confidence
  • Melania Trump's NFT sales and collectibles business made $6 million

    60% confidence
  • Trump made $236.3 million on World Liberty Financial token sales

    60% confidence
  • Trump made $65.6 million from selling part of his stake in World Liberty Financial

    60% confidence
  • People who bought assets launched by the president have lost roughly 98%

    60% confidence
  • Stablecoin consortiums like Open USD have never really worked in the past

    60% confidence
  • Trump earned $511k from Ethereum validator staking rewards

    60% confidence
  • As of May, the Trump Organization had made $2.29 billion total from crypto while investors had lost $2.28 billion

    60% confidence
  • In 2024, 54% of all the money Circle made went to Coinbase, amounting to just under a billion dollars

    60% confidence
  • In 2024, 99% of Circle's income came from holding treasuries

    60% confidence
  • Scott Melker is continuing to buy Bitcoin at a heavy rate because he believes a bottom is at or near

    60% confidence
  • Trump annihilated the anti-crypto regulatory army of the Biden/Gensler/Warren era, which is a huge net positive for the industry

    60% confidence
  • Taiwan's new crypto law includes prison terms of up to seven years for running an unlicensed exchange

    60% confidence
  • The Open USD announcement alone dropped Circle stock up to 17% in one day

    60% confidence
  • Trump made $196.9 million from the sale of his ownership interest in the USD1 stablecoin venture

    60% confidence
  • Citigroup does not believe crypto ETFs will see positive inflows at all for the next year

    60% confidence
  • The Trump token hit $74.24 the day after launch and is now down about 98%, with 80% of supply still held by insiders on a vesting schedule

    60% confidence
  • Trump made $635.1 million in fees on the Trump meme coin alone in 2025

    60% confidence

Data points we hold from this source

Donald Trump · net income1.4 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Trump made $1B on crypto, his buyers got crushed — Source | Via News | es.VIA.NEWS